| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A functional interaction between hepatic estrogen receptor-α and PNPLA3 p.I148M inherited variant drives fatty liver disease susceptibility in women
|
Cherubini, A.
|
|
|
55 |
S1 |
p. S13
|
article
|
| 2 |
A.I.S.F. 2023: Abstracts evaluation procedure
|
|
|
|
55 |
S1 |
p. S76
|
article
|
| 3 |
A new metabolic comorbidity score predicts risk of death among cirrhotic patients on waiting list for liver transplantation
|
Parisse, S.
|
|
|
55 |
S1 |
p. S24
|
article
|
| 4 |
A nutrigenetic precision approach for the management of NAFLD
|
Perez-Diaz-del-Campo, N.
|
|
|
55 |
S1 |
p. S23-S24
|
article
|
| 5 |
A simple characterization of dynamic changes in circulating CD8+PD1+ lymphocytes early predicts response to atezolizumab-bevacizumab in hepatocellular carcinoma
|
Giovannini, C.
|
|
|
55 |
S1 |
p. S13-S14
|
article
|
| 6 |
B-Klotho deficiency in hepatic stellate cells (HSCs) prompts inflammation, oxidative stress and a pro-fibrotic phenotype
|
Tria, G.
|
|
|
55 |
S1 |
p. S33
|
article
|
| 7 |
Bulevirtide improves health-related quality of life measured by EQ-5D VAS in patients with chronic hepatitis delta: An exploratory analysis of a Phase 3 trial at 48 weeks
|
Buti, M.
|
|
|
55 |
S1 |
p. S72-S73
|
article
|
| 8 |
Bulevirtide monotherapy is safe and well tolerated in patients with chronic hepatitis D (CHD): An integrated safety analysis of 48-week data
|
Asselah, T.
|
|
|
55 |
S1 |
p. S74
|
article
|
| 9 |
CAR-OLT score predicts cardiac contraindications to liver transplant and 1-year cardiovascular complications after transplant
|
Biolato, M.
|
|
|
55 |
S1 |
p. S15
|
article
|
| 10 |
Changing HCV patient profiles: insights from a large multinational real-world sofosbuvir/velpatasvir (SOF/VEL) dataset
|
Mangia, A.
|
|
|
55 |
S1 |
p. S71-S72
|
article
|
| 11 |
Characteristics and medium-term outcomes of a retrospective cohort of patients with non-malignant, non-cirrhotic splanchnic vein thrombosis
|
Gallo, C.
|
|
|
55 |
S1 |
p. S63-S64
|
article
|
| 12 |
Characterization of sarcopenia with ultrasound-based measurements in patients with advanced chronic liver disease.
|
Gallo, P.
|
|
|
55 |
S1 |
p. S70
|
article
|
| 13 |
Cholangiocarcinoma-on-chip: A 3D liver tumor platform for personalized medicine
|
Polidoro, M.A.
|
|
|
55 |
S1 |
p. S8
|
article
|
| 14 |
Cholestatic HCV-related cryoglobulinemia: A new clinical and pathological entity
|
Dalbeni, A.
|
|
|
55 |
S1 |
p. S40-S41
|
article
|
| 15 |
Circulating interleukin-32 levels are associated with arterial hypertension in individuals at risk of NAFLD
|
Tomasi, M.
|
|
|
55 |
S1 |
p. S35
|
article
|
| 16 |
Clinical application of NGS in the diagnosis of iron overload disorders or hyperferritinemia of genetic origin
|
Ricci, A.
|
|
|
55 |
S1 |
p. S72
|
article
|
| 17 |
Clinical impact and treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) after liver transplant (LT). The role of transjugular intrahepatic porto-systemic shunt (TIPS)
|
Triolo, M.
|
|
|
55 |
S1 |
p. S60
|
article
|
| 18 |
Clinical utility of a targeted panel sequencing for the diagnosis of chronic hereditary liver diseases in adult patients
|
Marini, I.
|
|
|
55 |
S1 |
p. S35
|
article
|
| 19 |
Combined hepatic and adipose tissue transcriptomics highlights circulating NASH biomarkers
|
Meroni, M.
|
|
|
55 |
S1 |
p. S32-S33
|
article
|
| 20 |
Comparison of metabolic alterations, hepatic and cardiovascular damage between primary NAFLD and HIV-associated NAFLD: Role of low visceral adiposity
|
Lombardi, R.
|
|
|
55 |
S1 |
p. S39-S40
|
article
|
| 21 |
Contribution of GD2 ganglioside to aggressivness of human cholangiocarcinoma
|
Mannini, A.
|
|
|
55 |
S1 |
p. S43
|
article
|
| 22 |
Coronary computed tomography angiography in pre-liver transplant cardiac work-up
|
Manuli, C.
|
|
|
55 |
S1 |
p. S31
|
article
|
| 23 |
Detection of hepatocellular carcinoma's microvascular invasion at the preoperative CT scan: Artificial intelligence meets radiomics
|
Famularo, S.
|
|
|
55 |
S1 |
p. S6
|
article
|
| 24 |
Echocardiography-based markers of subclinical cardiac dysfunction in individuals with Non-Alcoholic Fatty Liver Disease and preserved ejection fraction: Interim data from a prospective study
|
Armandi, A.
|
|
|
55 |
S1 |
p. S36
|
article
|
| 25 |
Editorial Board
|
|
|
|
55 |
S1 |
p. i-ii
|
article
|
| 26 |
Efficacy of a polyphenols enriched EVOO in MAFLD patients: a preliminary evaluation on cardiovascular risk, metabolism and liver function parameters.
|
Seidita, A.
|
|
|
55 |
S1 |
p. S57-S58
|
article
|
| 27 |
Efficacy of bulevirtide as monotherapy for chronic hepatitis D (CHD): Week 48 results from an integrated analysis
|
Lampertico, P.
|
|
|
55 |
S1 |
p. S73
|
article
|
| 28 |
Efficacy of lenvatinib in intermediate stage and advanced hepatocellular carcinoma: Results of monotherapy and combination with locoregional treatment
|
Giannelli, V.
|
|
|
55 |
S1 |
p. S68-S69
|
article
|
| 29 |
Enhanced detection of overt HBV infection in chronic HCV carriers
|
Mizzoni, K.
|
|
|
55 |
S1 |
p. S57
|
article
|
| 30 |
Epidemiological and clinical profile of HDV infected people in care in Italy: Interim analysis from the ongoing PITER cohort
|
|
|
|
55 |
S1 |
p. S61-S62
|
article
|
| 31 |
ePRO Diary: an App-based linkage to care model to promote compliance in pediatric liver transplant recipients in transition to adulthood
|
Pasulo, L.
|
|
|
55 |
S1 |
p. S62
|
article
|
| 32 |
Extension of Bulevirtide monotherapy to 72 weeks in HDV patients with compensated cirrhosis: Efficacy and safety from the italian multicenter study (HEP4Di)
|
Anolli, M.P.
|
|
|
55 |
S1 |
p. S7
|
article
|
| 33 |
Fatty Acid Synthase expression promotes the malignant features of cholangiocarcinoma cells and predicts shorter survival in patients
|
Lori, G.
|
|
|
55 |
S1 |
p. S14
|
article
|
| 34 |
Fully automated approach of machine learning combined with deep learning: How to predict the onset of major cardiovascular events in NAFLD patients
|
Cirella, A.
|
|
|
55 |
S1 |
p. S32
|
article
|
| 35 |
FVIII/PC and ADAMTS13/VWF ratio to predict liver-related events and mortality in patients with ACLD
|
Giuli, L.
|
|
|
55 |
S1 |
p. S41
|
article
|
| 36 |
Genetic characterization of a dysmetabolic and obese population of Southern Italy
|
Motta, B.M.
|
|
|
55 |
S1 |
p. S56-S57
|
article
|
| 37 |
Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic Hepatitis C aged 75 years or older: A multicenter study
|
Pugliese, N.
|
|
|
55 |
S1 |
p. S26
|
article
|
| 38 |
Glomerular Hyperfiltration is a new marker of fibrosis severity in non-cirrhotic NAFLD
|
Dalbeni, A.
|
|
|
55 |
S1 |
p. S48-S49
|
article
|
| 39 |
Group therapy for alcohol addiction treatment before liver transplantation reduces post-transplant alcohol relapse: preliminary results of a monocentric retrospective study
|
Costa, E. Garlatti
|
|
|
55 |
S1 |
p. S54
|
article
|
| 40 |
HBsAg kinetics during and after nucleos(t)ide analogues described by mathematical modeling
|
Colombatto, P.
|
|
|
55 |
S1 |
p. S62-S63
|
article
|
| 41 |
HBV/HDV coinfection: A long-lasting indication for liver transplantation
|
Manuli, C.
|
|
|
55 |
S1 |
p. S31
|
article
|
| 42 |
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV sub-genotypes 1 inducing different inflammatory stimuli
|
Salpini, R.
|
|
|
55 |
S1 |
p. S53-S54
|
article
|
| 43 |
Hepatitis D: A still relevant disease
|
Battistella, S.
|
|
|
55 |
S1 |
p. S44
|
article
|
| 44 |
Hepatocyte depletion of ERK5 impairs the response to lipotoxic oxidative stress resulting in defective insulin receptor signaling
|
Menconi, A.
|
|
|
55 |
S1 |
p. S49
|
article
|
| 45 |
High Incidence of sepsis caused by MDR bacteria in patients undergoing Percutaneous biliary drainage for the treatment of biliary obstruction
|
De Nicola, S.
|
|
|
55 |
S1 |
p. S51
|
article
|
| 46 |
Highlighting sex dimorphism in the molecular mechanisms responsible for sarcopenia in a murine model of liver fibrosis
|
Sayaf, K.
|
|
|
55 |
S1 |
p. S11
|
article
|
| 47 |
Impact of complications on long-term survival after pediatric liver transplantation
|
Leonardi, F.
|
|
|
55 |
S1 |
p. S58
|
article
|
| 48 |
Impact of Endoscopic Band Ligation on Bleeding Incidence in Patients with Chronic Liver Disease and High-Risk Varices
|
Gulotta, M.
|
|
|
55 |
S1 |
p. S49-S50
|
article
|
| 49 |
Improvement of clinical parameters in HDV patients with advanced compensated cirrhosis treated with Bulevirtide monotherapy for 48 weeks
|
Degasperi, E.
|
|
|
55 |
S1 |
p. S29
|
article
|
| 50 |
Incidence and predictors of hepatocellular carcinoma in autoimmune hepatitis: A multicenter international study
|
Colapietro, F.
|
|
|
55 |
S1 |
p. S8-S9
|
article
|
| 51 |
Incidence and risk factors of esophagogastric varices bleeding in cirrhotic patients with advanced hepatocellular carcinoma treated with lenvatinib
|
Iavarone, M.
|
|
|
55 |
S1 |
p. S67-S68
|
article
|
| 52 |
Increased level of presepsin in patients with acutely decompensated cirrhosis predicts development of acute-on-chronic liver failure
|
Zanetto, A.
|
|
|
55 |
S1 |
p. S2-S3
|
article
|
| 53 |
Independent determinants and predictors of controlled attenuation parameter (CAP) values in 1,230 individuals with metabolic dysfunction
|
Bianco, C.
|
|
|
55 |
S1 |
p. S53
|
article
|
| 54 |
Individualized HBIG withdrawal in an historical cohort of liver transplant recipients in Italy
|
Viganò, R.
|
|
|
55 |
S1 |
p. S50
|
article
|
| 55 |
Interferon gamma-induced protein 10 levels are associated with insulin resistant components in subjects with non-alcoholic fatty liver disease
|
Guariglia, M.
|
|
|
55 |
S1 |
p. S5
|
article
|
| 56 |
Intestinal activation of the lxr-α receptor protects the liver from NASH-related damage
|
Lioci, G.
|
|
|
55 |
S1 |
p. S46
|
article
|
| 57 |
It takes a team for HCC: The adverse events reduction in first line HCC systemic therapies with the multidisciplinary ambulatory
|
Dalbeni, A.
|
|
|
55 |
S1 |
p. S29
|
article
|
| 58 |
Lack of substantial improvements in the landscape of alcohol-related hepatocellular carcinoma in the last 15 years: The need to improve cancer prevention and surveillance
|
Reggidori, N.
|
|
|
55 |
S1 |
p. S16-S17
|
article
|
| 59 |
Lenvatinib for treatment of recurrence hepatocellular carcinoma after liver transplantation: A case series
|
Mazzarelli, C.
|
|
|
55 |
S1 |
p. S68
|
article
|
| 60 |
Liver function is a predictor of survival in patients with hepatocellular carcinoma in best supportive care
|
Campani, C.
|
|
|
55 |
S1 |
p. S74-S75
|
article
|
| 61 |
Liver health in patients with hemophilia: Residual risk factors of liver-related complications after HCV-clearance
|
La Mura, V.
|
|
|
55 |
S1 |
p. S65-S66
|
article
|
| 62 |
Liver transplantation for polycystic disease: A cumbersome benign disease
|
Calleri, A.
|
|
|
55 |
S1 |
p. S26-S27
|
article
|
| 63 |
Liver transplantation for portopulmonary hypertension responsive to targeted therapy
|
Calleri, A.
|
|
|
55 |
S1 |
p. S27
|
article
|
| 64 |
Liver transplant outcome of cirrhotic patients treated with coronary stenting and early discontinuation of dual antiplatelet therapy
|
Saracco, M.
|
|
|
55 |
S1 |
p. S28
|
article
|
| 65 |
Long-term outcomes of patients with chronic HBe-negative infection: Differences and transition between inactive carriers and low viremic carriers
|
Rizzo, G.E.M.
|
|
|
55 |
S1 |
p. S10-S11
|
article
|
| 66 |
Long-term results from the Italian real-world experience on obeticholic acid treatment in primary biliary cholangitis: The RECAPITULATE study
|
Terracciani, F.
|
|
|
55 |
S1 |
p. S44-S45
|
article
|
| 67 |
Long-term results of ab-initio introduction of everolimus after liver transplantation
|
Pedini, D.
|
|
|
55 |
S1 |
p. S19
|
article
|
| 68 |
Long-term survival in patients undergoing trans jugular intrahepatic portosystemic shunt placement after liver transplantation
|
Leonardi, F.
|
|
|
55 |
S1 |
p. S50-S51
|
article
|
| 69 |
Long-term treatment with fibrates and ursodeoxycholic acid in people with Primary Sclerosing Cholangitis is safe and associated with persistent clinical and biochemical improvement
|
Catanzaro, E.
|
|
|
55 |
S1 |
p. S59-S60
|
article
|
| 70 |
Low adherence to Mediterranean Diet is associated to sCD163 levels in patients with MAFLD
|
Perez-Diaz-del-Campo, N.
|
|
|
55 |
S1 |
p. S23
|
article
|
| 71 |
Lusutrombopag treatment in cirrhotic patients with low platelets count scheduled to undergo invasive procedures: A multicenter experience
|
Tizzani, M.
|
|
|
55 |
S1 |
p. S37-S38
|
article
|
| 72 |
Magnetic Resonance-based fibrosis markers in patients with Non-Alcoholic Fatty Liver Disease: Exploratory data from the Turin cohort
|
D'Amato, D.
|
|
|
55 |
S1 |
p. S22
|
article
|
| 73 |
Medium-term outcome of liver recipients from COVID-19 donors
|
Saracco, M.
|
|
|
55 |
S1 |
p. S27-S28
|
article
|
| 74 |
MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma
|
Galvani, G.
|
|
|
55 |
S1 |
p. S47
|
article
|
| 75 |
Mitochondrial Complex I modulator (CIM) reduces lipid accumulation and inflammation in MCD-diet fed rats
|
Di Pasqua, L.G.
|
|
|
55 |
S1 |
p. S29-S30
|
article
|
| 76 |
Myosteatosis is not associated with complications or survival in HCC patients undergoing transarterial embolization
|
Masetti, C.
|
|
|
55 |
S1 |
p. S47-S48
|
article
|
| 77 |
NAFLD and weight loss: The Salerno experience on close monitoring
|
Torre, P.
|
|
|
55 |
S1 |
p. S64-S65
|
article
|
| 78 |
Nationwide survey of liver transplantation for Primary Sclerosing Cholangitis in Italy
|
Morelli, M.C.
|
|
|
55 |
S1 |
p. S1
|
article
|
| 79 |
Network meta-analysis of first-line systemic therapies for advanced hepatocellular carcinoma: Who is the winner?
|
Celsa, C.
|
|
|
55 |
S1 |
p. S3
|
article
|
| 80 |
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease and type 2 diabetes
|
Pennisi, G.
|
|
|
55 |
S1 |
p. S12-S13
|
article
|
| 81 |
Obeticholic acid reduces lipid accumulation and fibrosis in a diet-induced ob/ob mouse model of NASH
|
Cagna, M.
|
|
|
55 |
S1 |
p. S30
|
article
|
| 82 |
Oleocanthalic acid extracted form extravirgin olive oil reduces fatty acid accumulation and fibrogenesis in experimental in vitro models of NAFLD and NASH
|
Zanotto, I.
|
|
|
55 |
S1 |
p. S66
|
article
|
| 83 |
Omicron SARS-CoV-2 variant outbreak in vaccinated liver transplant (LT) recipients in 2022: A large spread of infection, a mild disease
|
Donato, M.F.
|
|
|
55 |
S1 |
p. S34
|
article
|
| 84 |
Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes a pro-tumorigenic inflammatory response
|
Foglia, B.
|
|
|
55 |
S1 |
p. S34
|
article
|
| 85 |
Patient-derived liver organoids as an in vitro model to study new personalized therapies targeting VDAC1 in intrahepatic cholangiocarcinoma
|
De Siervi, S.
|
|
|
55 |
S1 |
p. S14
|
article
|
| 86 |
People with autoimmune hepatitis and celiac disease have a milder liver disease course and a better chance of immunosuppressive treatment withdrawal.
|
Pezzato, F.
|
|
|
55 |
S1 |
p. S63
|
article
|
| 87 |
Phenotypical and molecular landscape of B lymphocytes in patients with Intrahepatic Cholangiocarcinoma
|
Milardi, G.
|
|
|
55 |
S1 |
p. S37
|
article
|
| 88 |
PNPLA3, MBOAT7 and TM6SF2 modify mitochondrial dynamics in NAFLD patients: Dissecting the role of cell-free circulating mtDNA and copy number
|
Longo, M.
|
|
|
55 |
S1 |
p. S11
|
article
|
| 89 |
Post-liver transplantation recurrence of primary sclerosing cholangitis: role of autologous hematopoietic stem cell transplantation
|
Pasulo, L.
|
|
|
55 |
S1 |
p. S62
|
article
|
| 90 |
Prediction of response to obeticholic acid in primary biliary cholangitis: Development and validation of the OCA response score (ORS)
|
De Vincentis, A.
|
|
|
55 |
S1 |
p. S4-S5
|
article
|
| 91 |
Predictors of clinical trajectories in patients admitted for acutely decompensated cirrhosis: An external validation of the PREDICT study
|
Pompili, E.
|
|
|
55 |
S1 |
p. S6-S7
|
article
|
| 92 |
Predictors of extrahepatic recurrence after transarterial chemoembolization as first-line therapy for hepatocellular carcinoma
|
Pinto, E.
|
|
|
55 |
S1 |
p. S51-S52
|
article
|
| 93 |
Preliminary results of intrahospital HCV screening for elimination: A single center experience
|
Costa, E. Garlatti
|
|
|
55 |
S1 |
p. S43-S44
|
article
|
| 94 |
Preoperative predictors of recurrence beyond Milan criteria in hepatocellular carcinoma patients treated with frontline liver resection
|
Pelizzaro, F.
|
|
|
55 |
S1 |
p. S52-S53
|
article
|
| 95 |
Presence and severity of esophageal varices drives portal hypertension-related complications in compensated advanced nonalcoholic fatty liver disease
|
Pennisi, G.
|
|
|
55 |
S1 |
p. S21
|
article
|
| 96 |
Prevalence and predictiors of porto-sinusoidal vascular disorder in patients with constantly elevated gamma-glutamyl transferase levels: A multicenter Italian study
|
Pugliese, N.
|
|
|
55 |
S1 |
p. S48
|
article
|
| 97 |
Prevalence of hepatitis delta virus among chronic hbvcarriers at AOU Federico II
|
Cossiga, V.
|
|
|
55 |
S1 |
p. S19-S20
|
article
|
| 98 |
Primary biliary cholangitis case-finding: Monocentrical study on patients with incidental finding of anti-mitochondrial antibodies
|
Sciarrone, S.S.
|
|
|
55 |
S1 |
p. S24-S25
|
article
|
| 99 |
Prognostic impact of metastatic site in patients receiving first-line sorafenib therapy for advanced hepatocellular carcinoma
|
Ielasi, L.
|
|
|
55 |
S1 |
p. S42
|
article
|
| 100 |
Prognostic impact of previous intraarterial treatment in patients with hcc treated with sorafenib
|
Stefanini, B.
|
|
|
55 |
S1 |
p. S54-S55
|
article
|
| 101 |
Prognostic value of simple non-invasive tests for the risk stratification of hcc development in patients with cirrhosis due to non-alcoholic fatty liver disease
|
Abdulle, A.
|
|
|
55 |
S1 |
p. S23
|
article
|
| 102 |
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease
|
Pipitone, R.M.
|
|
|
55 |
S1 |
p. S7-S8
|
article
|
| 103 |
Prospective evaluation of screening strategies for NAFLD in people with type-2 diabetes mellitus in the community
|
Forlano, R.
|
|
|
55 |
S1 |
p. S17-S18
|
article
|
| 104 |
Prospective study on the prevalence of HCV infection in consecutive adult inpatients in a hospital division of Internal Medicine in Tuscany
|
Pacini, S.
|
|
|
55 |
S1 |
p. S30
|
article
|
| 105 |
Quality of life outcomes in people with Primary Biliary Cholangitis treated with obeticholic acid: results of a phase 4 real life observational trial
|
Rollo, P.
|
|
|
55 |
S1 |
p. S55
|
article
|
| 106 |
Quantitative HBV/HDV markers help to distinguish different clinic/virologic phases of chronic hepatitis delta
|
Ricco, G.
|
|
|
55 |
S1 |
p. S65
|
article
|
| 107 |
Recurrence of primary sclerosing cholangitis after liver transplantation: A single center data
|
Catanzaro, E.
|
|
|
55 |
S1 |
p. S60
|
article
|
| 108 |
Red rice (Monakoline K) effects on oxidative stress parameters and biomarkers of steatosis in mild hypercholesterolemic NAFLD patients
|
Romanin, A.
|
|
|
55 |
S1 |
p. S64
|
article
|
| 109 |
RESIST Criteria: A biochemical algorithm to reduce the number of unnecessary upper endoscopies for the evaluation of portal hypertension in compensated HBV-cirrhotic patients
|
Calvaruso, V.
|
|
|
55 |
S1 |
p. S38
|
article
|
| 110 |
Risk factors for viral reactivation in patients with overt or occult Hepatitis B Virus infection receiving immunosuppressive treatments: A systematic review and meta-analysis with decision curve analysis
|
Rizzo, G.E.M.
|
|
|
55 |
S1 |
p. S16
|
article
|
| 111 |
Role of extracellular vesicles in sarcopenia associated to chronic liver diseases
|
Barberi, L.
|
|
|
55 |
S1 |
p. S9
|
article
|
| 112 |
Role of non neoplastic portal vein thrombosis in natural history of patients with cirrhosis and hepatocellular carcinoma
|
Shalaby, S.
|
|
|
55 |
S1 |
p. S37
|
article
|
| 113 |
Role of the interplay between ERK5 and hypoxia in intrahepatic cholangiocarcinoma cells
|
Menconi, A.
|
|
|
55 |
S1 |
p. S49
|
article
|
| 114 |
RuvBL1 ATPase activity is essential for mitochondrial integrity and function in HCC cells
|
Simeone, I.
|
|
|
55 |
S1 |
p. S58-S59
|
article
|
| 115 |
RuvBL1 haploinsufficiency promotes hepatic lipid catabolism hampering NASH-HCC progression in mice
|
Guida, A.
|
|
|
55 |
S1 |
p. S55-S56
|
article
|
| 116 |
Safety and immunogenicity of booster dose in patients with chronic liver disease
|
Cossiga, V.
|
|
|
55 |
S1 |
p. S20
|
article
|
| 117 |
Salivary Analytical Device (SAD), a good tool for monitoring the metabolic status of patients with fatty liver disease
|
Sinatti, G.
|
|
|
55 |
S1 |
p. S41
|
article
|
| 118 |
Screening rate for Hepatitis D in Hepatitis B patients: Tips and tricks
|
Costa, E. Garlatti
|
|
|
55 |
S1 |
p. S43
|
article
|
| 119 |
Serum procalcitonin predicts mortality independently of the presence of ACLF in patients with cirrhosis and ascites hospitalized for suspicious infection and treated with empiric antibiotic therapy
|
Bianchini, M.
|
|
|
55 |
S1 |
p. S10
|
article
|
| 120 |
SGLT2 inhibitors improve hepatic fibrosis assessed by Fibroscan in NAFLD patients with type 2 diabetes: A five-year follow-up study
|
Lombardi, R.
|
|
|
55 |
S1 |
p. S42
|
article
|
| 121 |
Single centre experience with Nivolumab as monotherapy in chirrotic patients with advanced HCC.
|
Gaia, S.
|
|
|
55 |
S1 |
p. S61
|
article
|
| 122 |
SIRT5 rs12216101 T>G variant is associated with oxidative stress and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease
|
Salomone, F.
|
|
|
55 |
S1 |
p. S2
|
article
|
| 123 |
Social jetlag and mediterranean diet adherence are associated to liver fibrosis in patients with non-alcoholic fatty liver disease
|
Castelnuovo, G.
|
|
|
55 |
S1 |
p. S24
|
article
|
| 124 |
Survey on hepatic sarcoidosis in Italy
|
Corte, C. Della
|
|
|
55 |
S1 |
p. S69-S70
|
article
|
| 125 |
TERT-mutated hepatocellular carcinomas have a higher risk of recurrence after surgical resection. A monocentric prospective study
|
Vasuri, F.
|
|
|
55 |
S1 |
p. S21-S22
|
article
|
| 126 |
The burden of HDV infection: A ten-years’ experience of a sicilian tertiary centre of liver disease
|
Rizzo, G.E.M.
|
|
|
55 |
S1 |
p. S59
|
article
|
| 127 |
The CCAAT/Enhancer-Binding Protein beta - SerpinB3 axis inhibition as a novel strategy for Non-Alcoholic Steatohepatitis treatment
|
Martini, A.
|
|
|
55 |
S1 |
p. S39
|
article
|
| 128 |
The dietary supplementation with brown seaweeds and chromium picolinate improves NAFLD and NASH by modulating lipid metabolism and inflammation
|
Gabbia, D.
|
|
|
55 |
S1 |
p. S66-S67
|
article
|
| 129 |
The enigmatic immunoglobulin G4-related disease: A single-centre experience
|
Stegagnini, M.
|
|
|
55 |
S1 |
p. S28-S29
|
article
|
| 130 |
The impact of metabolic comorbidities and alcohol consumption on FIB-4 and NFS performance in MAFLD: A multicentric preliminary data
|
Cespiati, A.
|
|
|
55 |
S1 |
p. S38-S39
|
article
|
| 131 |
The invasion of the biliary epithelial cells by CD103+ CD69+ intraepithelial cells CD8+ T lymphocyte and its role in the pathogenesis of primary biliary cholangitis
|
Ronca, V.
|
|
|
55 |
S1 |
p. S3-S4
|
article
|
| 132 |
The overexpression of TM6SF2 and/or MBOAT7 wild-type genes restores the mitochondrial lifecycle and activity in an in vitro NAFLD model
|
Paolini, E.
|
|
|
55 |
S1 |
p. S33
|
article
|
| 133 |
The role of thyroid hormone signalling in liver carcinogenesis: A proof of knowledge
|
Pontillo, G.
|
|
|
55 |
S1 |
p. S20
|
article
|
| 134 |
The rs1468615 T>C in ABCB4 confers protection against gallstone disease but not against severe liver disease
|
Tavaglione, F.
|
|
|
55 |
S1 |
p. S25-S26
|
article
|
| 135 |
The use of AGILE 3+ and AGILE 4 for the prediction of advanced fibrosis and cirrhosis in patients with Non-Alcoholic Fatty Liver Disease
|
Gjini, K.
|
|
|
55 |
S1 |
p. S31-S32
|
article
|
| 136 |
TIPS under-dilation strategy with new controlled expansion endoprosthesis: A hemodynamic and imaging confirmation of its feasibility
|
Saltini, D.
|
|
|
55 |
S1 |
p. S56
|
article
|
| 137 |
Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: A single-center experience
|
Mazzarelli, C.
|
|
|
55 |
S1 |
p. S68
|
article
|
| 138 |
Trans-splenic anterograde coil assisted transvenous occlusion (TACATO) of gastric varices associated with gastrorenal shunt
|
Shalaby, S.
|
|
|
55 |
S1 |
p. S36
|
article
|
| 139 |
Tyrosol attenuates hepatic steatosis and fibrosis in a mouse model of NASH
|
Gabbia, D.
|
|
|
55 |
S1 |
p. S66
|
article
|
| 140 |
Use of psychiatric medication and drug interactions in patients with hcv infection treated with pangenotypic direct-acting antivirals
|
Turnes, J.
|
|
|
55 |
S1 |
p. S71
|
article
|
| 141 |
Validation of a targeted gene panel sequencing for the diagnosis of hereditary chronic liver diseases
|
Passignani, G.
|
|
|
55 |
S1 |
p. S11-S12
|
article
|
| 142 |
Validation of elastography criteria and cACLD Risk Model for diagnosis of compensated Advanced Chronic Liver Disease (cACLD) in NAFLD patients
|
Liguori, A.
|
|
|
55 |
S1 |
p. S15-S16
|
article
|
| 143 |
Verona liver day: Data of liver health from the Arena
|
Sacerdoti, D.
|
|
|
55 |
S1 |
p. S69
|
article
|
| 144 |
Which is the best therapy for not transplantable patients with multinodular early HCC?
|
Vitale, A.
|
|
|
55 |
S1 |
p. S40
|
article
|
Journal description